BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
ZBTB7A
,
glucose metabolic process
,
HIV infection
,
Retina
,
Laryngoscope
,
Phenobarbital
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
tasimelteon
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
The Involvement of Melatonin and Tasimelteon against Alzheimer's Disease.
Simulated driving performance in healthy adults after night-time administration of 20 mg tasimelteon…
Stability-indicating LC-MS/MS and LC-DAD methods for robust determination of tasimelteon and high re…
Tasimelteon safely and effectively improves sleep in Smith-Magenis syndrome: a double-blind randomiz…
Relationship Between Melatonin Receptor Agonists and Parkinson's Disease.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Evaluation of the Pharmacodynamic and Pharmacokinetic Interactions of Tasimelteon and Ethanol
Pharmacokinetics of Tasimelteon in Subjects With Mild or Moderate Hepatic Impairment
Open Label Study to Assess the Absolute Bioavailability of Tasimelteon (HETLIOZ™)
Study of the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents
Pharmacokinetics of Tasimelteon Alone and in Combination With CYP1A2 Inhibitor, Fluvoxamine
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ